{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:54:14Z","timestamp":1759366454118,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.revmed.2014.09.001","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T12:01:04Z","timestamp":1419854464000},"page":"491-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Rhumatisme psoriasique au cours d\u2019un traitement par rituximab pour une polyang\u00e9\u00efte avec granulomatose\u00a0: une nouvelle r\u00e9action paradoxale\u00a0?"],"prefix":"10.1016","volume":"36","author":[{"given":"A.","family":"Aussy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Girszyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Vandhuick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Marie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Vittecoq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"L\u00e9vesque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2014.09.001_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autrev.2013.06.005","article-title":"Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-\u03b1 agents","volume":"13","author":"Fiorino G1","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2014.09.001_bib0010","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1007\/s00296-012-2581-3","article-title":"Induced psoriasis after rituximab therapy for rheumatoid arthritis: a case report and review of the literature","volume":"33","author":"Guidelli","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.revmed.2014.09.001_bib0015","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/ard.2007.080929","article-title":"Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma","volume":"67","author":"Mielke","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2014.09.001_bib0020","first-page":"314","article-title":"Rituximab in rheumatoid arthritis: a systematic review of efficacy and safety","volume":"7","author":"Hernandez-Cruz","year":"2011","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.revmed.2014.09.001_bib0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/RHU.0b013e31816b4487","article-title":"Effect of rituximab on refractory Wegener granulomatosis with predominant granulomatous disease","volume":"14","author":"Sanchez-Cano","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.revmed.2014.09.001_bib0030","first-page":"2017","article-title":"Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations","volume":"35","author":"Seo","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2014.09.001_bib0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/annrheumdis-2011-200350","article-title":"European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies","volume":"71","author":"Gossec","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2014.09.001_bib0040","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaad.2010.10.041","article-title":"Methotrexate and psoriasis: consensus conference","volume":"64","author":"Kalb","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2014.09.001_bib0045","first-page":"446","article-title":"Proposed classification criteria of psoriatic arthritis. A preliminary study in 260\u00a0patients","volume":"66","author":"Fournie","year":"1999","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1016\/j.revmed.2014.09.001_bib0050","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2014.09.001_bib0055","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.3899\/jrheum.091280","article-title":"Increased risk of autoimmune disease in families with Wegener's granulomatosis","volume":"37","author":"Knight","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2014.09.001_bib0060","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.revmed.2013.04.016","article-title":"[Autoimmune blistering diseases]","volume":"35","author":"Duvert-Lehembre","year":"2014","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.09.001_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2014.09.001_bib0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1213277","article-title":"Efficacy of remission-induction regimens for ANCA-associated vasculitis","volume":"369","author":"Specks","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2014.09.001_bib0075","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/annrheumdis-2012-201956","article-title":"Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients","volume":"72","author":"Van Vollenhoven","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2014.09.001_bib0080","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/rheumatology\/kem299","article-title":"Progressive multifocal leucoencephalopathy in a patient with systemic lupus erythematosus treated with rituximab","volume":"47","author":"Harris","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2014.09.001_bib0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.medcli.2013.01.024","article-title":"Development of psoriasis in a patient with rheumatoid arthritis after rituximab","volume":"142","author":"Feced Olmos","year":"2014","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.revmed.2014.09.001_bib0090","first-page":"996","article-title":"Induction of psoriatic skin lesions in a patient with rheumatoid arthritis treated with rituximab","volume":"27","author":"Markatseli","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2014.09.001_bib0095","first-page":"926","article-title":"Worsening of psoriasis with rituximab therapy","volume":"28","author":"Olivieri","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2014.09.001_bib0100","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jbspin.2013.02.001","article-title":"Widespread psoriasis induced by rituximab in a patient with rheumatoid arthritis: an unexpected adverse reaction","volume":"80","author":"Ozen","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.revmed.2014.09.001_bib0105","first-page":"133","article-title":"Improvement in psoriasis during rituximab therapy for mixed cryoglobulinemia type II","volume":"86","author":"Moberg","year":"2010","journal-title":"Cutis"},{"key":"10.1016\/j.revmed.2014.09.001_bib0110","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1136\/annrheumdis-2012-201897","article-title":"Rituximab in psoriatic arthritis: an exploratory evaluation","volume":"71","author":"Jimenez-Boj","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2014.09.001_bib0115","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3899\/jrheum.111347","article-title":"Incidence of new-onset and flare of preexisting psoriasis during rituximab therapy for rheumatoid arthritis: data from the French AIR registry","volume":"39","author":"Thomas","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2014.09.001_bib0120","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.3748\/wjg.v18.i16.1871","article-title":"Colitis associated with biological agents","volume":"18","author":"Freeman","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.revmed.2014.09.001_bib0125","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/mus.23989","article-title":"Paradoxical worsening of anti\u2013myelin-associated glycoprotein polyneuropathy following rituximab","volume":"49","author":"Weiss","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.revmed.2014.09.001_bib0130","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.crohns.2012.08.007","article-title":"Induction or exacerbation of psoriatic lesions during anti-TNF-alpha therapy for inflammatory bowel disease: a systematic literature review based on 222\u00a0cases","volume":"7","author":"Denadai","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.revmed.2014.09.001_bib0135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jbspin.2011.10.001","article-title":"Development of inflammatory bowel disease during anti-TNF-\u03b1 therapy for inflammatory rheumatic disease: a nationwide series","volume":"79","author":"Toussirot \u00c91","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.revmed.2014.09.001_bib0140","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.revmed.2014.01.007","article-title":"[Paradoxical cutaneous reactions associated with tocilizumab therapy]","volume":"35","author":"Sparsa","year":"2014","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2014.09.001_bib0145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2014.09.001_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.gene.6364351","article-title":"Psoriasis: genetic associations and immune system changes","volume":"8","author":"Liu","year":"2007","journal-title":"Genes Immun"},{"key":"10.1016\/j.revmed.2014.09.001_bib0155","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5021\/ad.2010.22.4.397","article-title":"Role of CD4CD25FOXP3\u00a0regulatory T cells in psoriasis","volume":"22","author":"Yun","year":"2010","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.revmed.2014.09.001_bib0160","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.22081","article-title":"B-cell activation influences T-cell polarization and outcome of anti-CD20\u00a0B-cell depletion in central nervous system autoimmunity","volume":"68","author":"Weber","year":"2010","journal-title":"Ann Neurol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866314006249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866314006249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:34:36Z","timestamp":1759336476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866314006249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0248866314006249"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2014.09.001","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rhumatisme psoriasique au cours d\u2019un traitement par rituximab pour une polyang\u00e9\u00efte avec granulomatose\u00a0: une nouvelle r\u00e9action paradoxale\u00a0?","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2014.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}